Implementation Science Work Group, National Heart, Lung, and Blood Institute. Center for Translation Research and Implementation Science; National Heart, Lung, and Blood Institute. Veterans Affairs Medical Center, Memphis, TN. Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute. American Institutes for Research conducted the systematic review under a contract with the National Heart, Lung, and Blood Institute.
Circulation. 2017 Feb 28;135(9):e122-e137. doi: 10.1161/CIR.0000000000000481. Epub 2017 Jan 26.
In 2008, the National Heart, Lung, and Blood Institute convened an Implementation Science Work Group to assess evidence-based strategies for effectively implementing clinical practice guidelines. This was part of a larger effort to update existing clinical practice guidelines on cholesterol, blood pressure, and overweight/obesity.
Review evidence from the published implementation science literature and identify effective or promising strategies to enhance the adoption and implementation of clinical practice guidelines.
This systematic review was conducted on 4 critical questions, each focusing on the adoption and effectiveness of 4 intervention strategies: (1) reminders, (2) educational outreach visits, (3) audit and feedback, and (4) provider incentives. A scoping review of the Rx for Change database of systematic reviews was used to identify promising guideline implementation interventions aimed at providers. Inclusion and exclusion criteria were developed a priori for each question, and the published literature was initially searched up to 2012, and then updated with a supplemental search to 2015. Two independent reviewers screened the returned citations to identify relevant reviews and rated the quality of each included review.
Audit and feedback and educational outreach visits were generally effective in improving both process of care (15 of 21 reviews and 12 of 13 reviews, respectively) and clinical outcomes (7 of 12 reviews and 3 of 5 reviews, respectively). Provider incentives showed mixed effectiveness for improving both process of care (3 of 4 reviews) and clinical outcomes (3 reviews equally distributed between generally effective, mixed, and generally ineffective). Reminders showed mixed effectiveness for improving process of care outcomes (27 reviews with 11 mixed and 3 generally ineffective results) and were generally ineffective for clinical outcomes (18 reviews with 6 mixed and 9 generally ineffective results). Educational outreach visits (2 of 2 reviews), reminders (3 of 4 reviews), and provider incentives (1 of 1 review) were generally effective for cost reduction. Educational outreach visits (1 of 1 review) and provider incentives (1 of 1 review) were also generally effective for cost-effectiveness outcomes. Barriers to clinician adoption or adherence to guidelines included time constraints (8 reviews/overviews); limited staffing resources (2 overviews); timing (5 reviews/overviews); clinician skepticism (5 reviews/overviews); clinician knowledge of guidelines (4 reviews/overviews); and higher age of the clinician (1 overview). Facilitating factors included guideline characteristics such as format, resources, and end-user involvement (6 reviews/overviews); involving stakeholders (5 reviews/overviews); leadership support (5 reviews/overviews); scope of implementation (5 reviews/overviews); organizational culture such as multidisciplinary teams and low-baseline adherence (9 reviews/overviews); and electronic guidelines systems (3 reviews).
The strategies of audit and feedback and educational outreach visits were generally effective in improving both process of care and clinical outcomes. Reminders and provider incentives showed mixed effectiveness, or were generally ineffective. No general conclusion could be reached about cost effectiveness, because of limitations in the evidence. Important gaps exist in the evidence on effectiveness of implementation interventions, especially regarding clinical outcomes, cost effectiveness and contextual issues affecting successful implementation.
2008 年,美国国家心肺血液研究所召集实施科学工作组,评估将临床实践指南有效付诸实施的循证策略。这是更新关于胆固醇、血压和超重/肥胖的现有临床实践指南的更大努力的一部分。
回顾发表的实施科学文献中的证据,并确定增强临床实践指南采用和实施的有效或有希望的策略。
对 4 个关键问题进行了系统评价,每个问题都集中在 4 种干预策略的采用和有效性上:(1)提醒;(2)教育推广访问;(3)审核和反馈;(4)提供者激励。对 Rx for Change 数据库中的系统评价进行了广泛的回顾,以确定针对提供者的有前途的指南实施干预措施。为每个问题制定了事先的纳入和排除标准,并对最初的文献进行了搜索,截止日期为 2012 年,然后进行了补充搜索,截止日期为 2015 年。两名独立的审查员筛选了返回的引文,以确定相关的综述,并对每篇纳入综述的质量进行了评分。
审核和反馈以及教育推广访问通常对改善医疗流程(21 项综述中的 15 项和 13 项综述中的 12 项)和临床结果(12 项综述中的 7 项和 5 项综述中的 3 项)都有效。提供者激励对改善医疗流程(4 项综述中的 3 项)和临床结果(3 项综述均为有效、混合和无效)的效果不一。提醒对改善医疗流程结果的效果不一(27 项综述中有 11 项混合和 3 项一般无效),对临床结果一般无效(18 项综述中有 6 项混合和 9 项一般无效)。教育推广访问(2 项综述)、提醒(4 项综述中的 3 项)和提供者激励(1 项综述中的 1 项)通常可降低成本。教育推广访问(1 项综述)和提供者激励(1 项综述)在成本效益结果方面也通常是有效的。阻碍临床医生采用或遵守指南的障碍包括时间限制(8 项综述/综述);有限的人员配备资源(2 项综述);时间安排(5 项综述/综述);临床医生的怀疑态度(5 项综述/综述);临床医生对指南的了解(4 项综述/综述);以及临床医生的年龄较高(1 项综述)。促进因素包括指南的格式、资源和最终用户参与(6 项综述/综述);让利益相关者参与(5 项综述/综述);领导支持(5 项综述/综述);实施范围(5 项综述/综述);组织文化,如多学科团队和低基线依从性(9 项综述/综述);以及电子指南系统(3 项综述)。
审核和反馈以及教育推广访问策略通常可有效改善医疗流程和临床结果。提醒和提供者激励的效果不一,或者一般无效。由于证据的局限性,无法对成本效益做出一般结论。在实施干预措施的有效性方面,特别是在临床结果、成本效益和影响成功实施的背景问题方面,证据仍存在重要差距。